| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in ANIP over the last quarter tilts toward selling: insiders offloaded a net 30,412 shares worth roughly $2.2M. In the past 30 days, 0 insiders bought and 3 sold. The bias lately has been to the sell side.
On the other side, 3 insiders reduced their position over the period. ANIP sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 333.7K | $23.99M | -5,400 | |
| CFO | 169.0K | $12.34M | -2,850 | |
| COO | 101.1K | $7.80M | - | |
| Other | 91.3K | $6.54M | - | |
| VP | 75.5K | $5.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | Carey Stephen P.55 | SVP &CFO | Sell | 2,850 | $81.36 | $231,876.00 | -1.6% | -11.2% | - | |
| Jul 13, 2026 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 500 | $81.84 | $40,920.00 | -0.6% | -9.2% | - | |
| Jul 2, 2026 | Carey Stephen P.55 | SVP &CFO | Sale+OE | 3,313 | $86.00 | $284,918.00 | -1.8% | -15.6% | - | |
| Jun 29, 2026 | Carey Stephen P.55 | SVP &CFO | Sell | 2,850 | $84.12 | $239,742.00 | -1.6% | -11.0% | - | |
| Jun 12, 2026 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 500 | $82.03 | $41,015.00 | -0.6% | -12.5% | - | |
| Jun 8, 2026 | Haughey Thomas | Director | Sell | 2,000 | $80.88 | $161,760.00 | -4.9% | -12.4% | - | |
| Jun 5, 2026 | Carey Stephen P.55 | SVP &CFO | Sale+OE | 3,312 | $80.00 | $264,960.00 | -1.8% | -11.2% | - | |
| May 13, 2026 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 500 | $78.16 | $39,080.00 | -0.6% | -7.9% | - | |
| May 13, 2026 | Walsh Patrick D52 | Director | Sell | 13,973 | $80.66 | $1,127,119.75 | -26.7% | -7.9% | - | |
| May 12, 2026 | Gutwerg Ori47 | SVP, Generics | Sell | 2,772 | $79.50 | $220,374.00 | -3.4% | -4.7% | - |